Kaleida Capital
Overview
Kaleida Capital is an early-stage venture capital firm focused on neurotechnology and neuroscience innovation. The company invests in and supports companies that develop technologies for brain health, including AI/data analytics, diagnostics, biosensors, neuroimaging, neurostimulation, and drug discovery. The firm leverages the expertise of world-class engineers, investors, and policy leaders who have dedicated their careers to emerging technology for neuroscience innovation.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Aurenar | Jul 2026 | Seed | Co-investor |
| Manifest Technologies | Mar 2024 | Seed | Co-investor |
| Resonant Link Medical | Nov 2025 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Kaleida Capital based?
Kaleida Capital is headquartered in San Diego, California, United States.
When was Kaleida Capital founded?
Kaleida Capital was founded in 2022.
How many portfolio companies does Kaleida Capital have?
Kaleida Capital has 3 portfolio companies in Caplight's dataset.
What are some companies in Kaleida Capital's portfolio?
Portfolio companies visible on Caplight include Aurenar, Manifest Technologies, Resonant Link Medical.
What was Kaleida Capital's most recent investment shown here?
Kaleida Capital's most recent investment in this portfolio sample was in Aurenar in 2026.
What sectors does Kaleida Capital focus on?
Kaleida Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Kaleida Capital focus on?
Kaleida Capital typically invests at the Early stage.
What is Kaleida Capital's AUM?
Kaleida Capital's assets under management are estimated between $0.0 and $50.0M.